Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasm, Residual

Clinical trial condition

Neoplasm, Residual

Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.

194 public trials 80 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm, Residual trial results

Recruiting

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

NCT06463717

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease

NCT06253650

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +11 more
Locations: Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Milan, Italy

View Trial Details

Recruiting

Sweden Cancerome Analysis Network - Breast : Genomic Profiling of Breast Cancer

NCT02306096

Conditions: Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +9 more
Locations: Hallands Hospital Halmstad Halmstad, Sweden

Helsingborg Hospital Helsingborg, Sweden

Kirurgiska kliniken Jönköping, Sweden

Blekinge County Hospital Karlskrona, Sweden

View Trial Details

Recruiting

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

NCT06198868

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations: Jiangsu Cancer Institute & Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma

NCT06158269

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

A Study of Chidamide With AZA in MRD Positive AML After Transplant

NCT06066905

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

View Trial Details

Recruiting

Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRT

NCT05623267

Conditions: Limited Stage Small Cell Lung Cancer, Neoplasm, Residual, Neoplasms, +3 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Minimally Residual of Esophageal Cancer 001

NCT05952661

Conditions: Digestive System Diseases, Digestive System Neoplasms, Esophageal Carcinoma, +12 more
Locations: Fourth Hospital of Hebei Medical University Shijiazhuang, Hebei, China

View Trial Details

Recruiting

Clinical Research of Drug Holiday Based on MRD Detection in GIST Patients at High Risk of Recurrence

NCT05867901

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +10 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD

NCT05408897

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +11 more
Locations: Peking University People'S Hospital Beijing, Beijing Municipality, China

View Trial Details